22 May 2026
22 May 2026
Gilead will donate vials of its antifungal medication AmBisome to help global efforts in eliminating visceral leishmaniasis.
Cases of syphilis and gonorrhoea have tripled and quadrupled, respectively, since 2015 – highlighting the need for sound treatment and prevention methods.
The partnership will combine OpenBench’s discovery platform with Concept Life Sciences’ expertise in medicinal chemistry.
Gilead acquired all outstanding equity of Tubulis for $3.15bn upfront, plus up to $1.85bn in milestone payments.
Lilly’s takeover of Engage Bio marks the seventh acquisition for the big pharma since the start of 2026.
The healthcare team covers Q1 results from pharma and medtech companies and provides a wrap-up of the key takeaways.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
